Page last updated: 2024-10-22

acetohexamide and Xeroderma Pigmentosum

acetohexamide has been researched along with Xeroderma Pigmentosum in 1 studies

Acetohexamide: A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide.
acetohexamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is replaced by a p-acetylphenylsulfonyl group, while a hydrogen attached to the other nitrogen is replaced by a cyclohexyl group.

Xeroderma Pigmentosum: A rare, pigmentary, and atrophic autosomal recessive disease. It is manifested as an extreme photosensitivity to ULTRAVIOLET RAYS as the result of a deficiency in the enzyme that permits excisional repair of ultraviolet-damaged DNA.

Research Excerpts

ExcerptRelevanceReference
"The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries."2.61Novel therapeutic approaches to xeroderma pigmentosum. ( Glass, DA; Weon, JL, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Weon, JL1
Glass, DA1

Reviews

1 review available for acetohexamide and Xeroderma Pigmentosum

ArticleYear
Novel therapeutic approaches to xeroderma pigmentosum.
    The British journal of dermatology, 2019, Volume: 181, Issue:2

    Topics: Acetohexamide; Administration, Cutaneous; Animals; Caloric Restriction; Dermatology; Disease Models,

2019